MRK · 10-Q · 2026Q2 · Full report
German Health-Care Reform
Merck & Co., Inc. · 2026-08-07 · Importance 40 · Surprise 42 · In source text
Germany’s parliament approved the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-BStabG) in July 2026. Most provisions take effect January 1, 2027 and introduce cost-containment measures intended to reduce health-insurance expenditures. Merck expects the law to exert significant downward pressure on pharmaceutical sales in Germany and is evaluating its business implications.
Key facts
- In July 2026, the German parliament approved the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-BStabG), with the majority of provisions taking effect on January 1, 2027, and the law will exert significant downward pressure on sales in Germany. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | committed | — | In July 2026, the German parliament approved the Statutory Health Insurance Contribution Rate Stabilization Act (GKV-BStabG), with the… |